SPXC completed two significant acquisitions (Sigma Omega in April 2025 and Thermolec in January 2026) while adding new tariff-related risk language, driving substantial growth across key financial metrics.
The acquisitions appear to be executing successfully with meaningful revenue and profit growth, suggesting effective capital deployment and integration capabilities. However, the addition of specific tariff risk language indicates management's concern about trade policy impacts on their supply chain and pricing power, which investors should monitor given the global nature of their operations.
SPXC delivered robust financial performance with gross profit growing 21.9% to $162.2M and net income increasing 21.7% to $244.0M, likely driven by the recent acquisitions. The company significantly strengthened its balance sheet with cash more than doubling to $364.0M and stockholders' equity jumping 61.6% to $2.2B, while interest expense tripled to $27.2M reflecting acquisition financing. The strong operating cash flow growth of 16.6% to $333.3M demonstrates the underlying business is generating solid returns and successfully integrating the new acquisitions.
Interest expense surged 192.5% — significant debt increase or rising rates materially impacting earnings.
Cash position surged 132% — strong cash generation or capital raise providing significant financial cushion.
Equity base grew 61.6% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Current assets grew 45.8% — improving short-term liquidity or inventory/receivables build.
Asset base grew 32.8% — expansion through organic growth, acquisitions, or capital deployment.
Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.
Net income grew 21.7% — bottom-line growth signals improving overall business health.
R&D investment increased 17.6% — signals commitment to future product development, though near-term margin impact.
Operating cash flow grew 16.6% — strong conversion of earnings to cash, healthy business fundamentals.
SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →